Evidence map›Paper›PMID 34272254›Full record

ArticleBMJ open respiratory research2021

Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study.

Yuichiro Takeshita, Jiro Terada, Retsu Fujita, Yasutaka Hirasawa, Taku Kinoshita, Yuri Isaka, Toru Kinouchi, Hiroshi Tajima, Yuji Tada, Shigeru Kiryu and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open respiratory research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Coronary artery calcification as a predictor of adverse outcomes in patients hospitalized with COVID-19.American heart journal plus : cardiology research and practice · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yuichiro TakeshitaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Jiro TeradaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan jirotera@iuhw.ac.jp.
Retsu FujitaInnovation and Research Support Center, International University of Health and Welfare, Tokyo, Japan.
Yasutaka HirasawaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Taku KinoshitaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Yuri IsakaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Toru KinouchiDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Hiroshi TajimaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Yuji TadaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
Shigeru KiryuDepartment of Radiology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Kenji TsushimaDepartment of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Narita, Japan.
International University of Health and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough several studies have reported an association between atherosclerosis-related diseases and COVID-19, the relationship between COVID-19 severity and atherosclerosis progression remains unclear. The aim of this study is to determine the coronary artery calcium score (CACS) prognostic value in patients with COVID-19 using indices such as deterioration in oxygenation and CT images of the chest.

methodsThis was a single-centre retrospective study of 53 consecutive patients with COVID-19 in Narita who were admitted to our hospital between March 2020 and August 2020. CACS was calculated based on non-gated CT scans of the chest performed on admission day. The patients were divided into the following two groups based on CACS: group 1 (CACS ≥180, n=11) and group 2 (CACS <180, n=42). Following univariate analysis of the main variables, multivariate analysis of variables that may be associated with COVID-19 progression was performed.

resultsMultivariable logistic regression analysis of age, sex, smoking history, diabetes, hypertension, dyslipidaemia, number of days from symptom onset to hospitalisation and CACS of ≥180 was performed. It revealed that unlike CACS of <180, CACS of ≥180 is associated with exacerbation of oxygenation or CT images of the chest during hospitalisation (OR: 12.879, 95% CI: 1.399 to 380.401). Furthermore, this model of eight variables showed good calibration (Hosmer-Lemeshow p=0.119).

conclusionCACS may be a prognosis marker of COVID-19 severity. Although coronary artery calcification is not typically assessed in pneumonia cases, it may provide a valuable clinical indicator for predicting severe COVID-19 outcomes.

Indexed as

AgedAged, 80 and overCoronary Artery DiseaseCOVID-19Diabetes MellitusDisease ProgressionDyslipidemiasFemaleHospitalizationHumansHypertensionLength of StayLogistic ModelsMaleMiddle AgedMultivariate AnalysisCOVID-19viral infection

Identifiers

PMID34272254
PMCPMC8288241
OpenAlexW3182421099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.